{"id":21537,"date":"2016-08-28T05:00:48","date_gmt":"2016-08-27T23:30:48","guid":{"rendered":"https:\/\/cardiophile.org\/?p=21537"},"modified":"2021-12-20T22:44:43","modified_gmt":"2021-12-20T17:14:43","slug":"intravenous-p2y12-receptor-inhibitor-cardiology-mcq","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/","title":{"rendered":"Intravenous P2Y12 receptor inhibitor &#8211; Cardiology MCQ"},"content":{"rendered":"<p><span style=\"font-family: DejaVuSerif, sans-serif;\"><span style=\"font-size: small;\"><b>Intravenous <\/b><b>P2Y12<\/b><b>\u00a0receptor inhibitor:<\/b><\/span><\/span><br \/>\n<span style=\"font-family: DejaVuSerif, sans-serif;\">a) Ticagrelor<\/span><br \/>\n<span style=\"font-family: DejaVuSerif, sans-serif;\">b) Clopidogrel<\/span><br \/>\n<span style=\"font-family: DejaVuSerif, sans-serif;\">c) Prasugrel<\/span><br \/>\n<span style=\"font-family: DejaVuSerif, sans-serif;\">d) Cangrelor<\/span><br \/>\n<span style=\"font-family: DejaVuSerif, sans-serif;\"><span style=\"font-size: small;\"><b>Correct answer: d) Cangrelor<\/b><\/span><\/span><br \/>\n<span style=\"font-family: DejaVuSerif, sans-serif;\">Cangrelor is a reversible intravenous P2Y12\u00a0receptor inhibitor. It is a rapid and potent inhibitor of ADP induced platelet aggregation. Its plasma half life is less than 10 minutes and platelet function is restored within 2 hours of discontinuation of infusion.\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intravenous P2Y12\u00a0receptor inhibitor: a) Ticagrelor b) Clopidogrel c) Prasugrel d) Cangrelor Correct answer: d) Cangrelor Cangrelor is a reversible intravenous P2Y12\u00a0receptor inhibitor. It is a rapid and potent inhibitor of ADP induced platelet aggregation. Its plasma half life is less than 10 minutes and platelet function is restored within 2 hours of discontinuation of infusion.\u00a0<\/p>\n","protected":false},"author":1,"featured_media":17493,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[2,3,5],"tags":[],"class_list":["post-21537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology","category-cardiology-mcq","category-dm-dnb-cardiology-entrance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intravenous P2Y12 receptor inhibitor - Cardiology MCQ - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intravenous P2Y12 receptor inhibitor - Cardiology MCQ - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Intravenous P2Y12\u00a0receptor inhibitor: a) Ticagrelor b) Clopidogrel c) Prasugrel d) Cangrelor Correct answer: d) Cangrelor Cangrelor is a reversible intravenous P2Y12\u00a0receptor inhibitor. It is a rapid and potent inhibitor of ADP induced platelet aggregation. Its plasma half life is less than 10 minutes and platelet function is restored within 2 hours of discontinuation of infusion.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-27T23:30:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-20T17:14:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2014\/10\/cardiology-mcq5.png\" \/>\n\t<meta property=\"og:image:width\" content=\"701\" \/>\n\t<meta property=\"og:image:height\" content=\"517\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Intravenous P2Y12 receptor inhibitor &#8211; Cardiology MCQ\",\"datePublished\":\"2016-08-27T23:30:48+00:00\",\"dateModified\":\"2021-12-20T17:14:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/\"},\"wordCount\":65,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/cardiology-mcq5.png\",\"articleSection\":[\"Cardiology\",\"Cardiology MCQ\",\"DM \\\/ DNB Cardiology Entrance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/\",\"name\":\"Intravenous P2Y12 receptor inhibitor - Cardiology MCQ - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/cardiology-mcq5.png\",\"datePublished\":\"2016-08-27T23:30:48+00:00\",\"dateModified\":\"2021-12-20T17:14:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/cardiology-mcq5.png\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/cardiology-mcq5.png\",\"width\":701,\"height\":517},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intravenous P2Y12 receptor inhibitor &#8211; Cardiology MCQ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intravenous P2Y12 receptor inhibitor - Cardiology MCQ - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/","og_locale":"en_US","og_type":"article","og_title":"Intravenous P2Y12 receptor inhibitor - Cardiology MCQ - All About Cardiovascular System and Disorders","og_description":"Intravenous P2Y12\u00a0receptor inhibitor: a) Ticagrelor b) Clopidogrel c) Prasugrel d) Cangrelor Correct answer: d) Cangrelor Cangrelor is a reversible intravenous P2Y12\u00a0receptor inhibitor. It is a rapid and potent inhibitor of ADP induced platelet aggregation. Its plasma half life is less than 10 minutes and platelet function is restored within 2 hours of discontinuation of infusion.\u00a0","og_url":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2016-08-27T23:30:48+00:00","article_modified_time":"2021-12-20T17:14:43+00:00","og_image":[{"width":701,"height":517,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2014\/10\/cardiology-mcq5.png","type":"image\/png"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Intravenous P2Y12 receptor inhibitor &#8211; Cardiology MCQ","datePublished":"2016-08-27T23:30:48+00:00","dateModified":"2021-12-20T17:14:43+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/"},"wordCount":65,"commentCount":0,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2014\/10\/cardiology-mcq5.png","articleSection":["Cardiology","Cardiology MCQ","DM \/ DNB Cardiology Entrance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/","url":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/","name":"Intravenous P2Y12 receptor inhibitor - Cardiology MCQ - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2014\/10\/cardiology-mcq5.png","datePublished":"2016-08-27T23:30:48+00:00","dateModified":"2021-12-20T17:14:43+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2014\/10\/cardiology-mcq5.png","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2014\/10\/cardiology-mcq5.png","width":701,"height":517},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/intravenous-p2y12-receptor-inhibitor-cardiology-mcq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Intravenous P2Y12 receptor inhibitor &#8211; Cardiology MCQ"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=21537"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21537\/revisions"}],"predecessor-version":[{"id":52381,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21537\/revisions\/52381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/17493"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=21537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=21537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=21537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}